Cancer

MyOme and Ms.Medicine Announce Strategic Partnership to Redefine Personalized Primary Care Through Genomics

MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling…

2 days ago

Key Narmafotinib Patent Granted in the U.S.

Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent…

2 days ago

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary…

3 days ago

The Frederick Arts Council Presents “Where Energy Meets Matter: Exploring the Frontiers of Science” in partnership with the Frederick National Laboratory for Cancer Research

FREDERICK, Md., Dec. 2, 2025 /PRNewswire/ -- The "Where Energy Meets Matter" exhibition will run through January 20, 2026, at…

3 days ago

Function Accelerates AI and Personalization with Strategic Hire, Ziad Sultan, from Spotify to serve as Chief Product and Technology Officer

Following a $298M Series B, Function is accelerating technology and product leadership to expand AI capabilities and its Medical Intelligence…

3 days ago

Bridge To A Cure Foundation Welcomes Winston Ely to Board of Directors

FORT MYERS, Fla., Dec. 2, 2025 /PRNewswire/ -- Bridge To A Cure Foundation announces the appointment of Winston Ely to its…

3 days ago

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on…

3 days ago

Top Workplace Converted to Santa’s Workshop on Giving Tuesday to Spread ‘Big Love’ This Holiday Season

US Med-Equip Elves Helping Non-Profit Supporting Hospitalized Children with Cancer HOUSTON, TX / ACCESS Newswire / December 2, 2025 /…

3 days ago